WÄSSRIGE FORMULIERUNG MIT 5-AMINOLEVULINSÄURE ODER DERGLEICHEN

Patent europeic · EP3508200 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3508200
Numer da la dumonda
EP17846245
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
23-08-2017
Publitgà
10-07-2019
Concedì
10-04-2024
La protecziun finescha il pli tard
22-08-2037
Proxima taxa annuala scadenta
31-08-2026
Classas IPC
A61K 31/197 (2006.01)
A61K 31/22 (2006.01)
A61K 31/221 (2006.01)
A61K 31/222 (2006.01)
A61K 31/295 (2006.01)
A61K 9/06 (2006.01)
A61K 9/08 (2006.01)
A61K 47/02 (2006.01)
A61K 47/12 (2006.01)
Prioritad
JP 2016171753 02.09.2016
Dumonda PCT
PCT/JP2017/030107 23.08.2017
Publicaziun PCT
WO2018/043240 08.03.2018
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2025

    Midada

    Published in Swissreg on 01.09.2025

  2. 19-02-2025

    Midada

    Published in Swissreg on 19.02.2025

  3. 01-09-2024

    Midada

    Published in Swissreg on 01.09.2024

  4. 19-04-2024

    Represchentant inscrit

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 19.04.2024

  5. 10-04-2024

    Concedì

    Published in Swissreg on 10.04.2024

Partidas

Possessur

SBI Pharmaceuticals Co., Ltd.

6-1, Roppongi 1-chome Minato-ku, Tokyo 106-6020, JP

Represchentant

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventur

MORISHITA, Mika

Kobe-shi Hyogo 650-0047, JP

ISHIZUKA, Masahiro

Tokyo 106-6020, JP

OTA, Urara

Kobe-shi Hyogo 650-0047, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.